GlaxoSmithKline Pharmaceuticals informs about institutional investors meeting

13 Mar 2023 Evaluate

Pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that Analyst or Institutional Meetings with the Company is schedule on 16th March 2023 at 4.30 pm to 5.45 pm virtually. Link to Join the meeting is attached.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2476.65 11.75 (0.48%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×